⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RXRX News
Recursion Pharmaceuticals, Inc. Class A Common Stock
As AI Models Become Commodities, One Bio-Native AI Company Just Moved to Patent the Thing That Actually Compounds: the Data
prnewswire.com
ABCL
HYFT
SDGR
RXRX
TEM
A Clinical-Stage Cancer Company Is Putting AI to Work Designing Its Next Generation of Tumor-Targeting Drugs
prnewswire.com
CMPX
NKTX
GTBP
RXRX
FATE
Form 8-K
sec.gov
RXRX
The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It
prnewswire.com
HYFT
SDGR
RXRX
ABSI
CERT
Recursion to Participate in Upcoming Investor Conferences
globenewswire.com
RXRX
Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules
globenewswire.com
RXRX
Hydraulic Cylinder Market to Reach US$22.7 Billion by 2032 Expands Amid Industrial Growth and Smart Automation - Persistence Market Research
prnewswire.com
PH
ETN
RXRX
CAT
Altitude Lab Portfolio Companies Surpass $205 Million in Funding, Marking a New Era for Early-Stage Biotechs in Salt Lake City
globenewswire.com
RXRX
The Future of Intoxication Detection May Be in Your Voice
globenewswire.com
HTFL
RXRX
TEM
BFLY
PARP Inhibitors Clinical Trial Pipeline Accelerates as 25+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
globenewswire.com
AZN
MRK
JNJ
PFE
ABBV
GSK
ALLR
SNY
CURI
ORIC
EXEL
ABSI
LLY
TLX
FPH
BMY
SNX
XNCR
ZENA
ARVN
MGNX
DASH
VERU
GILD
EVGN
GEN
AMGN
MIR
RXRX
BG
MTX
BIO